Stay updated on Efgartigimod SC in ITP: Clinical Trial
Sign up to get notified when there's something new on the Efgartigimod SC in ITP: Clinical Trial page.
Latest updates to the Efgartigimod SC in ITP: Clinical Trial page
- Check2 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check24 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
- Check53 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check60 days agoChange DetectedA new version (v2.13.2) of the Phase 3 study on Efgartigimod PH20 for Primary Immune Thrombocytopenia has been added, replacing the previous version (v2.12.2) from November 2023.SummaryDifference2%
- Check74 days agoChange DetectedThe website has removed a detailed section regarding data download options, including file formats and various study-related fields.SummaryDifference14%
Stay in the know with updates to Efgartigimod SC in ITP: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efgartigimod SC in ITP: Clinical Trial page.